Cibus (NASDAQ:CBUS) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Cibus (NASDAQ:CBUS) from a sell rating to a hold rating in a report issued on Saturday.

Separately, Weiss Ratings downgraded Cibus from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Monday, June 29th. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $9.00.

Cibus Stock Down 4.5%

NASDAQ CBUS opened at $1.70 on Friday. The company has a 50-day simple moving average of $1.50 and a two-hundred day simple moving average of $1.97. Cibus has a 12-month low of $1.09 and a 12-month high of $4.19. The firm has a market cap of $129.76 million, a price-to-earnings ratio of -0.86 and a beta of 1.65.

Cibus (NASDAQ:CBUS) last released its quarterly earnings data on Thursday, May 14th. The company reported ($0.33) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.06). The company had revenue of $1.68 million during the quarter, compared to analysts’ expectations of $1.61 million. Cibus had a negative return on equity of 200.87% and a negative net margin of 2,366.33%. Equities analysts expect that Cibus will post -1.05 earnings per share for the current fiscal year.

Institutional Trading of Cibus

Several large investors have recently bought and sold shares of the company. Rockland Trust Co. purchased a new stake in shares of Cibus in the 2nd quarter worth approximately $41,000. Bank of America Corp DE boosted its holdings in Cibus by 324.2% in the first quarter. Bank of America Corp DE now owns 74,358 shares of the company’s stock worth $147,000 after acquiring an additional 56,830 shares in the last quarter. Weiss Asset Management LP bought a new stake in Cibus in the first quarter worth $1,758,000. OMERS ADMINISTRATION Corp purchased a new stake in shares of Cibus in the first quarter worth $66,000. Finally, Renaissance Technologies LLC increased its holdings in shares of Cibus by 42.5% during the first quarter. Renaissance Technologies LLC now owns 98,900 shares of the company’s stock valued at $196,000 after acquiring an additional 29,500 shares in the last quarter. 33.81% of the stock is owned by institutional investors.

Cibus Company Profile

Cibus, Inc is a biotechnology company specializing in precision gene editing for agricultural applications. Leveraging its proprietary Rapid Trait Development System (RTDS), Cibus develops improved crop traits without the introduction of foreign DNA. The company’s platform enables targeted modifications to plant genomes, allowing for enhanced disease resistance, herbicide tolerance and yield optimization in key row crops.

The company’s core business centers on trait development services and licensing partnerships.